Optiscan Imaging Ltd
ASX:OIL
Relative Value
The Relative Value of one OIL stock under the Base Case scenario is 0.009 AUD. Compared to the current market price of 0.092 AUD, Optiscan Imaging Ltd is Overvalued by 90%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
OIL Competitors Multiples
Optiscan Imaging Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
AU |
Optiscan Imaging Ltd
ASX:OIL
|
76.9m AUD | 45.7 | -14.1 | -12 | -12 | ||
US |
Abbott Laboratories
NYSE:ABT
|
184.4B USD | 4.6 | 32.8 | 19.3 | 28.8 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
137.8B USD | 18.8 | 69.3 | 56.9 | 71.3 | ||
US |
Stryker Corp
NYSE:SYK
|
126.1B USD | 6 | 37.5 | 24.4 | 30 | ||
IE |
Medtronic PLC
NYSE:MDT
|
109B USD | 3.4 | 25.9 | 13.8 | 19.5 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
107.9B USD | 7.3 | 61.1 | 30.7 | 45.4 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
68.6B USD | 3.5 | 56.2 | 18.8 | 39.7 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
58B EUR | 2.7 | 38.2 | 18.4 | 31 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
376.8B CNY | 11 | 33.2 | 29 | 29 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
51.7B USD | 8.4 | 36.5 | 26.5 | 28.7 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
51.4B USD | 13.5 | 80.4 | 60.1 | 78.3 |